08/18/2025
3:42 PM | CDT Equity Inc. (Subject)
CDT Equity Inc. (Subject)
CDT Equity Inc. (Subject)
Conduit Pharmaceuticals (Subject)
CDT Equity Inc. (Subject)
Sarborg Ltd (Filed by)
| Form SCHEDULE 13G/A | |
08/14/2025
12:11 PM | CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
Conduit Pharmaceuticals (Filer)
CDT Equity Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2025
3:15 PM | CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
Conduit Pharmaceuticals (Filer)
CDT Equity Inc. (Filer)
| Form 424B3 | |
08/11/2025
4:12 PM | CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
Conduit Pharmaceuticals (Filer)
CDT Equity Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2025
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
07/31/2025
6:46 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Corvus Capital Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
07/09/2025
11:04 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEF 14A | |
07/08/2025
4:24 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form ARS | |
06/13/2025
6:17 AM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2025
7:45 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CDT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/07/2025
4:35 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Sarborg Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/07/2025
4:36 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Sarborg Ltd (Filed by)
| Form SCHEDULE 13G | |
05/06/2025
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
04/25/2025
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
4:24 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/17/2025
3:05 PM | Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
4:14 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form PRE 14A | |
04/10/2025
5:00 AM | ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
| Form SCHEDULE 13G/A | |
04/01/2025
8:04 PM | Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:07 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:09 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:13 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Lewis-Hall Freda C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
4:23 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
3:54 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/10/2025
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B5 | |
03/06/2025
7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
3:32 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
| Form SCHEDULE 13G/A | |
02/19/2025
8:00 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B5 | |
02/12/2025
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
02/11/2025
7:00 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
4:19 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/06/2025
7:58 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B5 | |
02/05/2025
4:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/23/2025
7:15 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
| Form SCHEDULE 13G | |
01/15/2025
3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B5 | |
12/20/2024
4:05 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/20/2024
4:06 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:06 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Lewis-Hall Freda C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
US attacks China, September 30? (Ad) The White House just ordered more than 400 government agencies to prepare for the next phase of America’s economic war with China. But this time, it’s not about tariffs or tech bans—it’s a sweeping master plan designed to make the U.S. $50 trillion richer at China’s expense.
Treasury, Social Security, the Pentagon, and even the IRS are scrambling to meet the September 30 deadline. One expert says it could be the biggest economic development since the invention of the atomic bomb—and it could send trillions flowing into Americans’ pockets. Click here to see the full details of this government action plan and how to prepare before Sept. 30 |
12/20/2024
4:06 PM | Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:06 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
4:01 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
12/09/2024
7:30 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEF 14A | |
12/08/2024
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
12/09/2024
5:11 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
11/26/2024
4:21 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form PRE 14A | |
11/25/2024
4:10 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/25/2024
3:53 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:20 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:22 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q/A | |
11/14/2024
4:24 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q/A | |
11/14/2024
4:27 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
5:01 AM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
St George Street Capital (Filed by)
| Form SC 13G/A | |
11/04/2024
4:20 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
11/04/2024
4:21 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B5 | |
11/03/2024
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
11/01/2024
4:10 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEFA14A | |
11/01/2024
3:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEF 14A | |
10/28/2024
4:16 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form DEFA14A | |
10/28/2024
4:17 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form ARS | |
10/24/2024
5:12 AM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/18/2024
3:15 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/16/2024
4:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form PRE 14A | |
10/15/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
5:01 AM | ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
| Form SC 13G | |
10/07/2024
6:36 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
| Form SC 13G/A | |
10/07/2024
6:38 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:02 PM | CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:59 PM | CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Corvus Capital Ltd. (Filed by)
| Form SC 13D/A | |
09/19/2024
4:01 PM | Algo Holdings, Inc. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:41 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
09/16/2024
11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
09/06/2024
4:00 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
3:44 PM | CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
MarketBeat All Access